数字农科院2.0

Genetic Evolution during the development of an attenuated EIAV vaccine

文献类型： 外文期刊

作者： Wang, Xue-Feng;Lin, Yue-Zhi;Li, Qiang;Liu, Qiang;Zhao, Wei-Wei;Du, Cheng;Chen, Jie;Wang, Xiaojun;Zhou, Jian-Hua;Wang, Xue-Feng;Li, Qiang;Zhou, Jian-Hua

作者机构：

关键词： EIAV;Genetic Evolution;Lentiviral vaccine

期刊名称： RETROVIROLOGY

ISSN： 1742-4690

年卷期： 2016 年 13 卷

页码：

收录情况： SCI

摘要： Background: The equine infectious anemia virus (EIAV) vaccine is the only attenuated lentiviral vaccine applied on a large scale that has been shown to be effective in controlling the prevalence of EIA in China. This vaccine was developed by successive passaging of a field-isolated virulent strain in different hosts and cultivated cells. To explore the molecular basis for the phenotype alteration of this vaccine strain, we systematically analyzed its genomic evolution during vaccine development. Results: Sequence analysis revealed that the genetic distance between the wild-type strain and six representative strains isolated from key development stages gradually increased with the number of passages. Env gene, but not gag and pol, showed a clear evolutionary flow similar to that of the whole genomes of different generations during the attenuation. Stable mutations were identified in multiple regions of multiple genes along with virus passaging. The adaption of the virus to the growth environment of cultured cells with accumulated genomic and genetic variations was positively correlated with the reduction in pathogenicity and rise of immunogenicity. Statistical analyses revealed significant differences in the frequency of the most stable mutations between in vivo and ex vivo-adapted strains and between virulent and attenuated strains. Conclusions: These data indicate that EIAV evolution during vaccine development generated an accumulation of mutations under the selective drive force, which helps to better understand the molecular basis of lentivirus pathogenicity and immunogenicity.

分类号：

  • 相关数据
  • 相关文献

[1]MOESM2 of Genetic Evolution during the development of an attenuated EIAV vaccine. Li, Qiang,Wang, Xue-Feng,Xiaojun Wang,Chen, Jie,Yue-Zhi Lin,Liu, Qiang,Zhou, Jian-Hua,Du, Cheng,Zhao, Wei-Wei

[2]Genetic Evolution during the development of an attenuated EIAV vaccine. Zhao, Wei-Wei,Yue-Zhi Lin,Du, Cheng,Xiaojun Wang,Li, Qiang,Liu, Qiang,Chen, Jie,Wang, Xue-Feng,Zhou, Jian-Hua

[3]MOESM1 of Genetic Evolution during the development of an attenuated EIAV vaccine. Du, Cheng,Yue-Zhi Lin,Xiaojun Wang,Liu, Qiang,Zhou, Jian-Hua,Li, Qiang,Chen, Jie,Wang, Xue-Feng,Zhao, Wei-Wei

[1]Evaluation of genetic identity and variation in cultivars of Pyrus pyrifolia (Burm.f.) Nakai from China using microsatellite markers. Cao, Y.,Yang, J.,Zhang, S.,Cao, Y.,Tian, L.,Gao, Y..

[2]Molecular Epidemic Characteristics and Genetic Evolution of Porcine Circovirus Type 2 (PCV2) in Swine Herds of Shanghai, China. Le Kang,Abdul Wahaab,Kun Shi,Bahar E. Mustafa,Yan Zhang,Junjie Zhang,Zongjie Li,Yafeng Qiu,Beibei Li,Ke Liu,Donghua Shao,Zhiyong Ma,Dengke Zhong,Jianchao Wei. 2022

[3]Investigation of porcine circovirus type 2 and porcine circovirus type 3 infections based on dual TaqMan fluorescent quantitative PCR method and genetic evolutionary analysis of these two viruses. Mengxiang Cao,Yanwu Wei,Weilin Shi,Li Feng,Liping Huang. 2024

[4]Genetic evolution and alterations in pathogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus. Chao Li,Hu Xu,Jinhao Li,Bangjun Gong,Zhenyang Guo,Lirun Xiang,Siyu Zhang,Qi Sun,Jing Zhao,Menglin Zhang,Chaoliang Leng,Kuan Zhao,Jianan Wu,Qian Wang,Jinmei Peng,Guohui Zhou,Huairan Liu,Tongqing An,Xuehui Cai,Zhi Jun Tian,Yan Dong Tang,Hongliang Zhang. 2025

[5]Genetic Epidemiology of Porcine Epidemic Diarrhea Virus Circulating in China From 2010 to 2024: Characterization of Phylogenetic and Genetic Diversity of S1-Based Genes. Jing Sun,Jiongze Cheng,Da Shi,Xiangwen Xu,Yijia Liu,Jiale Ying,Yulin Zhao,Huihua Zheng,Junfang Yan,Dongbo Sun,Houhui Song,Mingjun Su. 2025

[6]Analysis of genomic selection characteristics of local cattle breeds in Gansu. Bao Cai,Yandong Kang,Lin Xiong,Jie Pei,Qianyun Ge,Xiaoyun Wu,Manyu Gan,Xian Guo. 2025

[7]Global evolution dynamics of genotype VI NDVs and dissection of the biological properties of strains from the prevalent sub-genotypes. Di, Tao,Han, Zongxi,Li, Huixin,Shao, Yuhao,Sun, Junfeng,Liu, Shengwang. 2025

[8]Global dissemination and evolutionary dynamics of duck hepatitis A virus type 3 driven by VP1 gene variation. Zhao, Saisai,Hao, Yizhang,Zhang, Qing,Li, Bing,Fan, Yaru,Liu, Guocheng,Li, Yiman,Zhang, Jiahao,Tang, Yi,Diao, Youxiang. 2025

[9]TEA5K: a high-resolution and liquid-phase multiple-SNP array for molecular breeding in tea plant. Liu, Dingding,Zhang, Chenyu,Ye, Yuanyuan,Mei, Piao,Gong, Yang,Liu, Zhen,Sun, Chao,Zhao, Xuecheng,Ding, Shiqi,Chen, Jiedan,Chen, Liang,Ma, Chunlei. 2025

[10]Epidemiology and Pathogenicity Analysis Based on Partial Recombinant PRRSV Strains in China. You, Shangshang,Li, Lingguang,Wang, Junna,Luo, Lingzhi,Song, Junhan,Ju, Houbin,Yu, Lingxue,Li, Guoxin,Cui, Jin. 2025

[11]马传染性贫血弱毒疫苗诱导的细胞免疫应答特点与免疫保护相关性研究. 林跃智,邓喜林,沈楠,吕晓玲,赵立平,邵一鸣,沈荣显,周建华. 2008

[12]以中国马传染性贫血病毒减毒疫苗为模型探索慢病毒免疫保护机理. 马建,林跃智,王雪峰,何翔,贾斌,梁华,沈弢,孟庆来,杜承,周建华,沈荣显,邵一鸣,王晓钧. 2014

[13]马传染性贫血病毒Gag p9蛋白功能研究进展. 魏丽丽,王晓钧,王盈,李景鹏,相文华,沈荣显. 2004

[14]EIAV基因转移载体启动子的比较. 韩凌霞,李亚明,曲连东,司昌德,姜骞,刘家森. 2006

[15]马传染性贫血病毒(EIAV)嵌合感染性分子克隆的体外构建. 涂亚斌,王柳,刘红全,仇华吉,童光志. 2001

[16]EIAV强毒株和弱毒疫苗株gp90基因差异与免疫原性关系研究. 王雪峰,杨彬,王帅,林跃智,吕晓玲,赵立平,王凤龙,周建华. 2008

[17]EIAV疫苗弱毒株诱导的超感染抵制现象与其诱导天然免疫激活间的相关性研究. 马建,王珊珊,林跃智,王雪峰,杜承,周建华. 2012

[18]EIAV驴白细胞弱毒疫苗株减毒过程第61代毒前病毒全基因组DNA的克隆与分析. 赵薇薇,王雪峰,马建,吕晓玲,赵玉军,周建华. 2008

[19]EIAV减毒疫苗克隆株诱导体液免疫反应的时相研究. 阳凯,孟庆来,陈新江,马燕,相文华,张耀洲,邵一鸣,张晓燕. 2009

[20]马传贫病毒主要基因变异研究进展. 耿庆华,相文华. 2005

作者其他论文 更多>>